NCT05422521View on ClinicalTrials.gov

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 29, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions
Refractory or Relapsed Non-Hodgkin's Lymphoma
Interventions
OTHER

blood samples and 18FDG PET-CT exams

"* 18 FDG PET scanner at inclusion and post CART-cells treatment ( 1, 3, 6, 9 and 12 month)~* blood collection at inclusion and post CART-cells treatment (7 days, 1 month and 3 month)"

Trial Locations (1)

06000

RECRUITING

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER